Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...

Researchers at the University of Illinois at Chicago have taken the dangerous guesswork out of dosing a lifesaving medication for congestive heart failure. A new formula developed in the UIC College ...

Recommendations for digoxin use in patients with HF have changed only slightly with the 2005 guidelines. [1] The primary change was to reclassify the recommendation for use from Class I, evidence ...

Although no dosage adjustments are believed to be necessary for the combination of zaleplon and digoxin, the digoxin dosage should be modified if indicated by the patient's response and the results of ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...